Literature DB >> 7968208

Prednisolone pharmacodynamics: leukocyte trafficking in the rat.

J A Wald1, W J Jusko.   

Abstract

Leukocytes circulate throughout the body patrolling for foreign antigens and facilitating immune responses. Corticosteroids exert their immunosuppressive actions, in part, by inhibiting the normal trafficking of these cells. The rat was used to investigate corticosteroid-induced changes in circulating total lymphocytes, CD4+ cells, and granulocytes. Prednisolone doses of 5, 25, and 50 mg/kg or saline were given i.v. Blood was taken over 24 hr for analysis of cell subsets by flow cytometry. Steroid exposure was assessed by assaying plasma prednisolone by HPLC. Response profiles were complicated, possibly by opposing effects on the recirculation of cells to blood. This prospect was investigated using pharmacodynamic cell trafficking models. Steroid-like effects in saline treated animals that may be due to stress or other factors limited data interpretation. As an animal model to characterize cell trafficking actions, the rat is an imperfect model.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7968208     DOI: 10.1016/0024-3205(94)00693-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Pharmacokinetic and pharmacodynamic interactions between dehydroepiandrosterone and prednisolone in the rat.

Authors:  G M Meno-Tetang; Y Y Hon; S Van Wart; W J Jusko
Journal:  Drug Metabol Drug Interact       Date:  1999

2.  Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran; Debra C DuBois; Richard R Almon; Jun Qu; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-27       Impact factor: 2.745

3.  Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in rabbits.

Authors:  G M Ferron; W J Jusko
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

4.  Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats.

Authors:  G M Ferron; N A Pyszczynski; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

Review 5.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

Review 6.  Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.

Authors:  Troels K Bergmann; Katherine A Barraclough; Katie J Lee; Christine E Staatz
Journal:  Clin Pharmacokinet       Date:  2012-11       Impact factor: 6.447

7.  Population pharmacokinetic/pharmacodynamic modeling of systemic corticosteroid inhibition of whole blood lymphocytes: modeling interoccasion pharmacodynamic variability.

Authors:  Ying Hong; Donald E Mager; Robert A Blum; William J Jusko
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.